Venturi Ventures Inc, formerly Urodynamix Technologies ltd is engaged in the development of non invasive medical technology and diagnostic devices based on near infrared spectroscopy and the development and marketing of its Advanced Verification of Integration Dose technology. The Company had developed and commercialized a medical device to aid in the diagnosis and treatment of urinary incontinence and lower urinary tract symptoms and had developed a portfolio of technology to aid in the diagnosis of intra-abdominal pressure that cause abdominal compartment syndrome and improve the efficacy of the minimally invasive treatment of benign prostatic hypertrophy.